The Oxido-Metabolic Driver ATF4 Enhances Temozolamide Chemo-Resistance in Human Gliomas

Oncotarget - United States
doi 10.18632/oncotarget.17737
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Activation of the PERK-ATF4 Pathway Promotes Chemo-Resistance in Colon Cancer Cells

Scientific Reports
Multidisciplinary
2019English

LMTK3 Confers Chemo-Resistance in Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Glypican-1 Is Frequently Overexpressed in Human Gliomas and Enhances FGF-2 Signaling in Glioma Cells

American Journal of Pathology
Forensic MedicinePathology
2006English

Fasting Enhances the Response of Glioma to Chemo- And Radiotherapy

PLoS ONE
Multidisciplinary
2012English

Microenvironment in Determining Chemo-Resistance in Pancreatic Cancer: Neighborhood Matters

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2017English

Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas

Oncotarget
Oncology
2016English

WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Allostery Modulates Resistance Driver Mutations in TEM-1

Biophysical Journal
Biophysics
2019English

Chemo Resistance of Breast Cancer Stem Cells

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy